Navigation Links
Drug fends off kidney cancer progression
Date:5/16/2008

eiving placebo.

For almost 20 years, we made no headway in the management of advanced kidney cancer, notes Dr. Motzer. Recently, the identification of several new angiogenesis- targeted agents has provided us with new treatment options and an improved outlook for patients with advanced kidney cancer. Based on the results of this trial, everolimus could become another tool in our armamentarium and, in the future, kidney cancer is likely to be managed as a chronic disease with these types of treatment advances.

Everolimus was well tolerated by patients and the most common side effects were mouth ulcers, anemia, skin rash and weakness.


'/>"/>

Contact: Jeanne D'Agostino
dagostij@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Michael Moore Defends 9/11 Rescue Workers and Criticizes Insurance Industry on California Nurses Association Press Call
2. Mediterranean Diet for Mom Fends Off Asthma, Allergies in Kids
3. American Red Cross Defends Use of Emblem and Mission
4. Drew Carey Defends Medical Marijuana
5. Vitamin D Use Linked to Lower Mortality in Kidney Patients
6. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
7. AUA 2008: Global warming may lead to increase in kidney stones disease
8. Acrylamide Raises Kidney Cancer Risk
9. Gene Variant Boosts Risk of Severe Diabetic Eye, Kidney Diseases
10. The 29th Annual DC101 Chili Cook-Off Benefiting the National Kidney Foundation
11. Kidney Trouble Short-Lived in Most Liver Transplant Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
...ldren can be treated effectively with a single dos...ajor global health problem particularly in // chil...resource-limited countries where cholera occurs, a...tant as it reduces the demands on the healthcare s...
... effective in prevent the brain damages similar to...th Florida have found that a component of green te...ns of mice genetically programmed to develop the n... component, called epigallocatechin-3-gallate (EGC...
...t smoking is injurious to health. The maximum harm...cts of smoking may be understood by the effect it ...xidase A (MAOA) is important in mood regulation an... regulate blood pressure. In a new study, research...
...hange the curriculum for medicine by integrating m...ment it within two years. "Today's medical curric...ation of both the modern and traditional practices... to come out within two years time," said health m...
Other Medicine News:
(Date:7/24/2008)...gned to take body temperature, for home,and clinic...ll/ --- Kidz-Med, Inc.,(subsidiary of American Sci...States distributor of the Thermofocus(R) 5-in-1 no...results of a clinical study,conducted by the Secon...,Milan, Italy, which proves that the Thermofocus(R...
(Date:7/23/2008)...-- Sound Pharmaceuticals (SPI) has filed,an Invest...e clinical,testing of a proprietary formulation of...d hearing loss or ototoxicity. The oral capsule,co...nced stage lung cancer,and head and neck cancer pa... marks the second development program for SPI to e...
(Date:7/23/2008)...irstCall/ -- Dendreon Corporation,(Nasdaq: DNDN )...ata,Monitoring Committee (IDMC) to review in Octob...elating to the Company,s Phase 3 IMPACT (IMmunothe...nown as D9902B) clinical trial,of PROVENGE(R) (sip...nal,active cellular immunotherapy for the treatmen...
(Date:7/22/2008)...cs Development Initiative bring MJFF,s,current act...anuary 20,2009, NEW YORK, July 22 /PRNewswire-US...ery of transformative treatments and a cure for Pa...or Parkinson,s Research has awarded,$2.7 million i...e awards,were granted under MJFF,s Therapeutics De...
Breaking Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 1Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 2Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 3DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 1DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 2DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 3Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 1Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 2Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 1Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 2
...RIDGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - Comb...ed the presentation of,additional data related to ...2 and CRx-139, at the European League Against,Rheu...ting, June,13-16, 2007 in Barcelona, Spain., CRx-1...e and Chondrocyte,Inflammatory Mediators by CRx-10...
...FORD, Conn.--(BUSINESS WIRE)--Jun 13, 2007 - Neuro...t data from previous,Phase 1 and Phase 2a clinical...or the treatment of insomnia, were presented in tw... Associated,Professional Sleep Societies (APSS) in...dies with NG2-73 in chronic insomnia patients,are ...
Other Medicine Technology:Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: